Immune modulator therapy for microscopic colitis in a case series of 73 patients.

Cotter, T G; Kamboj, A K; Hicks, S B; Tremaine, W J; Loftus, E V; Pardi, D S

Cotter, T G; Kamboj, A K; Hicks, S B; Tremaine, W J; Loftus, E V; Pardi, D S.

Affiliation

Cotter TG; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Kamboj AK; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Hicks SB; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Tremaine WJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Loftus EV; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Aliment Pharmacol Ther ; 46(2): 169-174, 2017 07.

Article in En | MEDLINE | ID: mdl-28488312

Subject(s)

Budesonide/therapeutic use; Colitis, Microscopic/drug therapy; Methotrexate/therapeutic use; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Adult; Colitis, Collagenous/drug therapy; Colitis, Lymphocytic/drug therapy; Female; Humans; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Tumor Necrosis Factor-alpha / Budesonide / Colitis, Microscopic Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google